Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > FDA approval
View:
Post by Solid1 on Jul 24, 2024 1:35pm

FDA approval

Everything stands or falls with FDA approval - that's the only thing that counts. But you don't even know the pharmaceutical partner or the exact status. The notification may come at any time or it may never come
Comment by QContinuum1 on Jul 24, 2024 1:43pm
Don't agree.  Even without Epidiolex, there is enough business in Germany, Brazil and Australia to drive the SP to multiples from here. Pharma is the unicorn moonshot but I agree that we shouldn't but any value to it yet but I disagree that we don't know about it.  We know it's Epidiolex, we know the partner is one of the patent litigants and one of the ones that hasn ...more  
Comment by Solid1 on Jul 24, 2024 1:53pm
A new treatment with a generic of Epidiolex is not excluded by a patent! And where do you see that we have one of these partners? 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities